Pharmacokinetics, Relative Bioavailability and Safety of Xaracoll Implant
Status:
Completed
Trial end date:
2015-03-23
Target enrollment:
Participant gender:
Summary
Assess the pharmacokinetic profile of 2 doses of the XaraColl® implant after open laparotomy
hernioplasty and assess the relative bioavailability of Xaracoll compared to a local
bupivacaine infiltration.